Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

NCT00775073 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
INDIV
Sponsor class

Conditions

Interventions

Sponsor

Gerhard Treiber

Collaborators